Histological and biochemical considerations in the treatment of oral cancer with preoperative methotrexate infusion.
D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D007263:Infusions, Parenteral; D008727:Methotrexate / Q000008:administration & dosage*; D009062:Mouth Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D011300:Preoperative Care; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D004273:DNA, Neoplasm; D014316:Tritium; D013936:Thymidine; D008727:Methotrexate